Singleton J A, Greby S M, Wooten K G, Walker F J, Strikas R
Epidemiology and Surveillance Division, National Immunization Program, USA.
MMWR CDC Surveill Summ. 2000 Sep 22;49(9):39-62.
PROBLEM/CONDITION: An increasing proportion of adults have received recommended vaccinations against influenza, pneumococcal infection, and tetanus. However, in 1995, fewer than 60% of adults were vaccinated as recommended.
1993-1997.
Data were obtained from the state-based Behavioral Risk Factor Surveillance System (BRFSS) for 1993, 1995, and 1997 and from the National Health Interview Survey (NHIS) for 1995 to describe national, regional, and state-specific patterns of use of influenza and pneumococcal vaccines and tetanus toxoid among noninstitutionalized adults aged > or = 18 years.
Among adults aged > or = 65 years in 1995, 58% reported receiving an influenza vaccination during the previous 12 months, and 34% reported ever receiving a pneumococcal vaccination. In this age group, non-Hispanic whites were more likely to report receipt of influenza (61%) and pneumococcal vaccines (36%) than non-Hispanic blacks (40% and 22%, respectively) and Hispanics (50% and 23%, respectively). Among the 50 states and the District of Columbia, the median vaccination level among older adults (i.e., persons aged > or = 65 years) increased from 51% in 1993 to 66% in 1997 for influenza vaccine, and from 28% in 1993 to 46% in 1997 for pneumococcal vaccine. Adults with chronic medical conditions had low vaccination levels. Those aged 50-64 years were more likely than those aged 18-49 years to report influenza (38% versus 20%) and pneumococcal vaccination (20% versus 12%). In 1995, the proportion of adults who reported receiving a tetanus vaccination during the previous 10 years decreased with age, from 65% among those aged 18-49 years to 54% among those aged 50-64 years and to 40% among those aged > or = 65 years. In each age group, women were less likely than men to report receiving tetanus toxoid; and among adults aged > or = 65 years, Hispanics and Asians/Pacific Islanders were least likely among all racial/ethnic groups to report receiving tetanus toxoid.
By 1995, the Healthy People 2000 objective to increase to at least 60% the proportion of persons aged > or = 65 years who had received annual influenza vaccination had been achieved among non-Hispanic whites (objective 20.11). However, substantial improvement is needed among non-Hispanic blacks, Hispanics, and adults aged < 65 years with high-risk medical conditions.
Continued surveillance of vaccine coverage among adults will direct attention to undervaccinated populations that may be disproportionately affected by vaccine-preventable diseases. Vaccination coverage data can be used to guide efforts to increase awareness among health-care providers and the public about the benefits of vaccination, establish systems to ensure that every contact with the health-care system is used to update vaccinations, and further support financial mechanisms to increase vaccine delivery.
问题/状况:越来越多的成年人接种了针对流感、肺炎球菌感染和破伤风的推荐疫苗。然而,1995年,只有不到60%的成年人按推荐接种了疫苗。
1993 - 1997年。
数据取自1993年、1995年和1997年基于各州的行为危险因素监测系统(BRFSS)以及1995年的国家健康访谈调查(NHIS),以描述18岁及以上非机构化成年人中流感疫苗、肺炎球菌疫苗和破伤风类毒素的全国、区域和各州具体使用模式。
1995年,65岁及以上的成年人中,58%报告在过去12个月内接种了流感疫苗,34%报告曾接种肺炎球菌疫苗。在这个年龄组中,非西班牙裔白人比非西班牙裔黑人(分别为40%和22%)以及西班牙裔(分别为50%和23%)更有可能报告接种过流感疫苗(61%)和肺炎球菌疫苗(36%)。在50个州和哥伦比亚特区,老年人(即65岁及以上人群)中流感疫苗接种率的中位数从1993年的51%升至1997年的66%,肺炎球菌疫苗接种率的中位数从1993年的28%升至1997年的46%。患有慢性疾病的成年人接种率较低。50 - 64岁的成年人比18 - 49岁的成年人更有可能报告接种过流感疫苗(38%对20%)和肺炎球菌疫苗(20%对12%)。1995年,报告在过去10年内接种过破伤风疫苗的成年人比例随年龄下降,从18 - 49岁人群中的65%降至50 - 64岁人群中的54%,再降至65岁及以上人群中的40%。在每个年龄组中,女性报告接种破伤风类毒素的可能性低于男性;在65岁及以上的成年人中,西班牙裔和亚裔/太平洋岛民在所有种族/族裔群体中报告接种破伤风类毒素的可能性最低。
到1995年,《健康人民2000》中关于将65岁及以上人群每年接种流感疫苗的比例提高到至少60%的目标在非西班牙裔白人中得以实现(目标20.11)。然而,非西班牙裔黑人、西班牙裔以及65岁以下患有高危疾病的成年人仍需大幅改善。
持续监测成年人的疫苗接种覆盖率将使人们关注那些可能受疫苗可预防疾病影响不成比例的接种不足人群。疫苗接种覆盖率数据可用于指导各项工作,以提高医疗服务提供者和公众对疫苗接种益处的认识,建立确保每次就医时都更新疫苗接种情况的系统,并进一步支持增加疫苗供应的财务机制